For-profit organizations · Halifax, Nova Scotia
ImmunoVaccine Technologies Inc.
- Total value
- $14.3M
- Agreements
- 19
- Programs
- 6
- First and latest
- 2008–2020
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated); ACOA — Business Development Program — Commercial Component (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Atlantic Innovation Fund (AIF) - II | Atlantic Canada Opportunities Agency | 2 | $5.9M |
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 3 | $3.3M |
| REGI - Business Scale-up and Productivity | Atlantic Canada Opportunities Agency | 2 | $1.9M |
| Business Development Program | Atlantic Canada Opportunities Agency | 3 | $717K |
| Innovation Assistance Program | National Research Council Canada | 1 | $640K |
| BDP - Productivity and Business Skills | Atlantic Canada Opportunities Agency | 2 | $100K |
Plus 6 agreements ($1.7M) where the department did not name a program.
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Sep 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Cyber Security AssistanceContribution | $25,000 |
| Sep 2020 | REGI - Business Scale-up and ProductivityAtlantic Canada Opportunities Agency | Contribution | $900,000 |
| Sep 2020 | REGI - Business Scale-up and ProductivityAtlantic Canada Opportunities Agency | Contribution | $1,000,000 |
| Sep 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | COVID-19 Response (VI): DPX-COVID-19 Clinical Development and DPX-CoVLP Proof-of-Concept StudyContribution | $2,655,429 |
| Apr 2020 | Innovation Assistance ProgramNational Research Council Canada | Innovation Assistance ProgramContribution | $640,332 |
| Apr 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Covid-19 Response: DPX-COVID-19: Neutralizing-epitope Based Synthetic Vaccine with Potential for Large Scale ProductionContribution | $636,596 |
| Feb 2015 | Business Development ProgramAtlantic Canada Opportunities Agency | Contribution | $394,826 |
| Mar 2013 | Program not namedNational Research Council Canada | Contribution | $497,285 |
| Mar 2013 | Program not namedNational Research Council Canada | Contribution | $443,478 |
| Mar 2013 | Program not namedNational Research Council Canada | Contribution | $407,699 |
| Nov 2012 | Program not namedNational Research Council Canada | Contribution | $49,458 |
| Sep 2011 | Atlantic Innovation Fund (AIF) - IIAtlantic Canada Opportunities Agency | Contribution | $2,944,000 |
| Mar 2011 | Business Development ProgramAtlantic Canada Opportunities Agency | Contribution | $77,000 |
| Mar 2010 | BDP - Productivity and Business SkillsAtlantic Canada Opportunities Agency | Contribution | $50,000 |
| Feb 2010 | Program not namedNational Research Council Canada | Contribution | $45,938 |
| Jul 2009 | Program not namedNational Research Council Canada | Contribution | $260,148 |
| Dec 2008 | Business Development ProgramAtlantic Canada Opportunities Agency | Contribution | $245,625 |
| Oct 2008 | Atlantic Innovation Fund (AIF) - IIAtlantic Canada Opportunities Agency | Contribution | $3,000,000 |
| Jul 2008 | BDP - Productivity and Business SkillsAtlantic Canada Opportunities Agency | Contribution | $49,500 |